MARKER THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
MARKER THERAPEUTICS, INC. (MRKR) had Additional Paid in Capital, Common Stock of $43.55 million as of 2012-12-31, per its 10-Q filed 2013-05-21.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2013-05-21
- 2012-12-31: Additional Paid in Capital, Common Stock $43.55M.
- 2012-09-30: Additional Paid in Capital, Common Stock $43.22M.
- 2012-06-30: Additional Paid in Capital, Common Stock $43.02M.
- 2012-03-31: Additional Paid in Capital, Common Stock $40.33M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2012-12-31 | $43.55M 10-Q · filed 2013-05-21 | |
| 2012-09-30 | $43.22M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $43.02M 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $40.33M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $39.94M 10-K · filed 2013-05-15 | |
| 2011-09-30 | $43.45M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $30.93M 10-Q · filed 2011-08-22 | |
| 2010-12-31 | $37.81M 10-K · filed 2012-04-16 | $27.84M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |